Power Law company profile

SinoTau

Biotech & Life Sciences · Changping District, China · Founded 2005

Sinotau Pharmaceutical Group, founded in 2005, focuses on providing integrated solutions for early prevention, diagnosis, and treatment of diseases through advanced radiopharmaceutical research and development (R&D). The company operates primarily in the healthcare sector, targeting both the Chinese market and international markets. Sinotau serves a diverse range of clients including hospitals, research institutions, and healthcare providers. Its business model revolves around the development, manufacturing, and distribution of radiopharmaceuticals, which are specialized drugs that contain radioactive substances used for diagnosis or treatment of diseases. The company generates revenue through the sale of these radiopharmaceutical products and by offering related services such as clinical academic promotion and quality manufacturing processes. Keywords: radiopharmaceuticals, early prevention, diagnosis, treatment, healthcare, R&D, manufacturing, clinical promotion, China, global.

Valuation

$500M–1B

Latest valuation · 2023

Unlock exact value

Headcount

<100

Current team size

Unlock exact value

Total funding● Pre-IPO

$100–500M

Unlock exact value

Investors

27 investors on SinoTau's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 2 investors entered at this stage

Winning Ventures

Qiming Venture Partners

Series B+ 25 investors entered at this stage

Hetang Venture Capital Management (Beijing)

Sinopharm Capital

Guoke Jiahe (Beijing) Investment Management

CICC

Longmen Capital

Everest Venture Capital

Deyi Investment

China Life Private Equity Investment

Centurium Capital

Guangdong Technology Financial Group

SDIC Venture Capital

Ennovation Ventures

Jimin Trust

Qing Shi Zhenhe

Chengming Capital

CITIC Securities

China Structural Reform Fund

CITIC Gold Stone Investment

GF Qianhe

Gage Finance

SDIC Chuangyi

Xinshang Investment

Zhongshan Venture Capital

Zhizhong Investment

Lide Measurement and Control

Global footprint

Where SinoTau has talent and traffic

Workforce by country

1 countries with
team presence

🇨🇳 China100%

1 country shown

Talent graph

The shape of SinoTau's talent

Dealroom maps SinoTau's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

2 team members profilednamed & role-tagged by Dealroom

11 employeestotal headcount

DimensionScore

AI Talent

Engineering

Product

Go-to-market

Leadership

Research

Book a demo to unlock SinoTau's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about SinoTau

An AI-synthesized read of the highest-engagement posts about SinoTau on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See SinoTau on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles